In vitro cytotoxicity of ranpirnase (onconase) in combination with components of R-CHOP regimen against diffuse large B cell lymphoma (DLBCL) cell line

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0

Abstract

Ranpirnase (onconase; ONC) is an endoribonuclease obtained from the frog Rana pipiens. This enzyme exhibits anticancer properties mediated by degradation of cellular RNA and induction of apoptosis. In this study we assessed cytotoxicity of ONC in combination with currently used anticancer drugs on a human diffuse large B-cell lymphoma (DLBCL)-derived cell line (Toledo). Cytotoxic activity was measured by the exclusion of propidium iodide assay while apoptosis was assessed using the annexin-V binding method. Additionally, flow cytometry was used to assess the decline of mitochondrial potential and to determine activation of caspases 3, 8 and 9. It was observed that in vitro treatment with ONC in combination with rituximab, mafosfamide, vincristine, doxorubicin, and dexamethasone (drugs corresponding with elements of R-CHOP regimen) resulted in increased cytotoxicity. As a result ONC showed marked cytotoxicity against Toledo cells. Importantly, in combination of ONC with drugs imitating the R-CHOP regimen, this effect was significantly intensified. The main mechanism responsible for this event was induction of apoptosis along a mitochondrial dependent pathway. In conclusion, these data indicate that further preclinical and eventually clinical studies assessing activity of ONC+R-CHOP treatment are warranted.

Authors and Affiliations

Agata Majchrzak, Magdalena Witkowska, Aleksandra Mędra, Małgorzata Zwolińska, Jakub Bogusz, Barbara Cebula-Obrzut, Zbigniew Darzynkiewicz, Tadeusz Robak, Piotr Smolewski

Keywords

Related Articles

Rola interleukiny 15 w nowotworzeniu

Interleukina 15 jest cytokiną o plejotropowym działaniu, należącą do rodziny cytokin zbudowanych z czterech α‑helis. Wykorzystując receptor składający się z kompleksu trzech białek: specyficznej dla IL15 podjednostki α (...

DNA methylation in obesity

The number of overweight and obese people is increasing at an alarming rate, especially in the developed and developing countries. Obesity is a major risk factor for diabetes, cardiovascular disease, and cancer, and in c...

Selected aspects of Clostridium difficile infection

Clostridium difficile pathogen is a cause of the most frequent nosocomial infection, which is antibiotic-associated diarrhea. Antibiotic treatment causes disruption of the microbiome balance, which makes the gut a friend...

Effects of lactoferrin on elicitation of the antigen-specific cellular and humoral cutaneous response in mice

Immune contact dermatitis is an inflammation of the skin resulting from exposure to allergens in the environment. The aim of this study was to compare the actions of lactoferrin (LF), a natural immunomodulator, on the el...

Classical oxazaphosphorines – metabolism and therapeutic properties – new implications

Cyclophosphamide (CPA) and ifosfamide (IFO) belong to oxazaphosphorine drugs and for a few decades have been widely used for treatment of solid tumours and haematological malignancies. Both drugs are administered in phar...

Download PDF file
  • EP ID EP67208
  • DOI -
  • Views 132
  • Downloads 0

How To Cite

Agata Majchrzak, Magdalena Witkowska, Aleksandra Mędra, Małgorzata Zwolińska, Jakub Bogusz, Barbara Cebula-Obrzut, Zbigniew Darzynkiewicz, Tadeusz Robak, Piotr Smolewski (2013). In vitro cytotoxicity of ranpirnase (onconase) in combination with components of R-CHOP regimen against diffuse large B cell lymphoma (DLBCL) cell line. Advances in Hygiene and Experimental Medicine, 67(0), 1166-1172. https://europub.co.uk/articles/-A-67208